262 related articles for article (PubMed ID: 37838322)
21. Autophagy enhanced the radioresistance of non-small cell lung cancer by regulating ROS level under hypoxia condition.
Chen X; Wang P; Guo F; Wang X; Wang J; Xu J; Yuan D; Zhang J; Shao C
Int J Radiat Biol; 2017 Aug; 93(8):764-770. PubMed ID: 28463025
[TBL] [Abstract][Full Text] [Related]
22. Lysyl oxidase mediates hypoxia-induced radioresistance in non-small cell lung cancer A549 cells.
Gong C; Gu R; Jin H; Sun Y; Li Z; Chen J; Wu G
Exp Biol Med (Maywood); 2016 Feb; 241(4):387-95. PubMed ID: 26515140
[TBL] [Abstract][Full Text] [Related]
23. Overcoming Radioresistance in Tumor Therapy by Alleviating Hypoxia and Using the HIF-1 Inhibitor.
Zhou X; Liu H; Zheng Y; Han Y; Wang T; Zhang H; Sun Q; Li Z
ACS Appl Mater Interfaces; 2020 Jan; 12(4):4231-4240. PubMed ID: 31912727
[TBL] [Abstract][Full Text] [Related]
24. A positive feedback circuit comprising p21 and HIF-1α aggravates hypoxia-induced radioresistance of glioblastoma by promoting Glut1/LDHA-mediated glycolysis.
Jin X; Kuang Y; Li L; Li H; Zhao T; He Y; Di C; Kang J; Yuan L; Yu B; Li Q
FASEB J; 2022 Mar; 36(3):e22229. PubMed ID: 35199870
[TBL] [Abstract][Full Text] [Related]
25. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M
BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042
[TBL] [Abstract][Full Text] [Related]
26. The effect of HIF-1α inhibition in breast cancer cells prior to doxorubicin treatment under conditions of normoxia and hypoxia.
Fourie C; du Plessis M; Mills J; Engelbrecht AM
Exp Cell Res; 2022 Oct; 419(2):113334. PubMed ID: 36044939
[TBL] [Abstract][Full Text] [Related]
27. Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy.
Meijer TW; Kaanders JH; Span PN; Bussink J
Clin Cancer Res; 2012 Oct; 18(20):5585-94. PubMed ID: 23071360
[TBL] [Abstract][Full Text] [Related]
28. Autophagy-regulating microRNAs: potential targets for improving radiotherapy.
Li H; Jin X; Chen B; Li P; Li Q
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1623-1634. PubMed ID: 29971533
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia inducible factor-1α/B-cell lymphoma 2 signaling impacts radiosensitivity of H1299 non-small cell lung cancer cells in a normoxic environment.
Wang G; Xiao L; Wang F; Yang J; Yang L; Zhao Y; Jin W
Radiat Environ Biophys; 2019 Aug; 58(3):439-448. PubMed ID: 31203382
[TBL] [Abstract][Full Text] [Related]
30. Significance of HIF-1-active cells in angiogenesis and radioresistance.
Harada H; Kizaka-Kondoh S; Li G; Itasaka S; Shibuya K; Inoue M; Hiraoka M
Oncogene; 2007 Nov; 26(54):7508-16. PubMed ID: 17563752
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-associated autophagy flux dysregulation in human cancers.
Fu J; Lin J; Dai Z; Lin B; Zhang J
Cancer Lett; 2024 May; 590():216823. PubMed ID: 38521197
[TBL] [Abstract][Full Text] [Related]
32. Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas.
Mudassar F; Shen H; O'Neill G; Hau E
J Exp Clin Cancer Res; 2020 Oct; 39(1):208. PubMed ID: 33028364
[TBL] [Abstract][Full Text] [Related]
33. Development of single nanometer-sized ultrafine oxygen bubbles to overcome the hypoxia-induced resistance to radiation therapy via the suppression of hypoxia-inducible factor‑1α.
Iijima M; Gombodorj N; Tachibana Y; Tachibana K; Yokobori T; Honma K; Nakano T; Asao T; Kuwahara R; Aoyama K; Yasuda H; Kelly M; Kuwano H; Yamanouchi D
Int J Oncol; 2018 Mar; 52(3):679-686. PubMed ID: 29393397
[TBL] [Abstract][Full Text] [Related]
34. Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy.
Zaffaroni M; Vincini MG; Corrao G; Marvaso G; Pepa M; Viglietto G; Amodio N; Jereczek-Fossa BA
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232638
[TBL] [Abstract][Full Text] [Related]
35. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
Vordermark D; Brown JM
Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
[TBL] [Abstract][Full Text] [Related]
36. The emerging role of hypoxia-inducible factor-2 involved in chemo/radioresistance in solid tumors.
Zhao J; Du F; Luo Y; Shen G; Zheng F; Xu B
Cancer Treat Rev; 2015 Jul; 41(7):623-33. PubMed ID: 25981453
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-induced autophagy as an additional mechanism in human osteosarcoma radioresistance.
Feng H; Wang J; Chen W; Shan B; Guo Y; Xu J; Wang L; Guo P; Zhang Y
J Bone Oncol; 2016 Jun; 5(2):67-73. PubMed ID: 27335774
[TBL] [Abstract][Full Text] [Related]
38. Targeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia-inducible factor-1alpha.
Kim WY; Oh SH; Woo JK; Hong WK; Lee HY
Cancer Res; 2009 Feb; 69(4):1624-32. PubMed ID: 19176399
[TBL] [Abstract][Full Text] [Related]
39. Targeting SLC25A10 alleviates improved antioxidant capacity and associated radioresistance of cancer cells induced by chronic-cycling hypoxia.
Hlouschek J; Ritter V; Wirsdörfer F; Klein D; Jendrossek V; Matschke J
Cancer Lett; 2018 Dec; 439():24-38. PubMed ID: 30205167
[TBL] [Abstract][Full Text] [Related]
40. A novel HIF-1α/VMP1-autophagic pathway induces resistance to photodynamic therapy in colon cancer cells.
Rodríguez ME; Catrinacio C; Ropolo A; Rivarola VA; Vaccaro MI
Photochem Photobiol Sci; 2017 Nov; 16(11):1631-1642. PubMed ID: 28936522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
